Canopy Growth Corp (TSE:WEED - Get Free Report)'s stock price shot up 14.6% on Tuesday . The stock traded as high as C$7.32 and last traded at C$6.90. 4,944,257 shares changed hands during trading, an increase of 141% from the average session volume of 2,055,220 shares. The stock had previously closed at C$6.02.
Analysts Set New Price Targets
Separately, Canaccord Genuity Group lowered their price target on Canopy Growth from C$5.00 to C$3.50 and set a "sell" rating for the company in a research report on Monday, August 12th.
Check Out Our Latest Report on WEED
Canopy Growth Trading Up 14.6 %
The stock has a market cap of C$585.53 million, a PE ratio of -0.87, a price-to-earnings-growth ratio of -0.01 and a beta of 1.79. The company has a debt-to-equity ratio of 117.00, a quick ratio of 2.32 and a current ratio of 2.15. The company has a 50 day moving average of C$6.83 and a two-hundred day moving average of C$9.57.
Insider Transactions at Canopy Growth
In other news, Director David Eric Klein sold 40,135 shares of the company's stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of C$8.35, for a total transaction of C$335,303.84. In other news, Director David Eric Klein sold 40,135 shares of the business's stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of C$8.35, for a total transaction of C$335,303.84. Also, Senior Officer Christelle Gedeon sold 16,788 shares of the stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of C$8.35, for a total value of C$140,253.67. Corporate insiders own 0.21% of the company's stock.
About Canopy Growth
(
Get Free Report)
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
